| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.3M | -21.2% |
| SG&A Expense | $14.1M | +1.2% |
| Operating Income | -$33.4M | +13.1% |
| Interest Expense | -$2.1M | -180.5% |
| Income Tax | $0 | — |
| Net Income | -$55.2M | -45.4% |
| EPS (Basic) | -$1.74 | -32.8% |
| EPS (Diluted) | -$1.74 | -32.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.7M | +189.9% |
| Current Assets | $103.8M | +182.1% |
| Total Assets | $106.9M | +159.4% |
| Current Liabilities | $37.5M | +164.6% |
| Long-term Debt | $1.7M | -85.1% |
| Total Liabilities | $40.5M | +42.5% |
| Stockholders' Equity | $66.3M | +420.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | +21.1% |
| Capital Expenditures | $16K | -96.5% |
| Investing Cash Flow | -$16K | +94.3% |
| Financing Cash Flow | $94.3M | — |
| Free Cash Flow | -$27.0M | +22.1% |